TrialESMO open2022

Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101.

Y Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.